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Introduction
The cohesin complex (Figure 1 ) was originally discovered as protein complex required for sister chromatid cohesion (SCC), a function which is conserved in all eukaryotes [1•]. Within the past eight years cohesin has emerged as an essential actor in virtually all aspects of chromosome biology, including chromosome segregation, maintenance of genome stability, regulation of gene expression, chromatin structure and 3D genome organisation.
Cohesin's ability to take part in these distinct pathways arises from its unique ability to create topological links between two segments of the chromatin fibre. The topological link between two sister chromatids confers sister chromatid cohesion (Figure 2A ). The same interaction is established at DNA double strand break sites and hold the sister strand in place as repair template ( Figure 2B ). Interactions between two regions of the same chromatid forms chromatin loops that built up the overall 3D topology of the chromatin fibre and mediate communication between genes and their regulatory elements through highly organised chromatin structure ( Figures 2C-D) .
Although the underlying molecular mechanisms may appear similar, these distinct functions of cohesin differ in important aspects, and the regulation of cohesin's "looping function" is not understood at all.
Mutations in genes encoding cohesin subunits or its regulators (sometimes collectively referred to as the cohesion apparatus) have been shown to cause various human disorders, in particular cancers (for review [2] ) and developmental syndromes that are discussed below.
Recent developments in chromatin conformation capture techniques have allowed describing chromatin folding at different scales, mapping binding sites of important factors (including cohesin) and correlating site occupancy by cognate factors to chromatin organisation and gene activity.
In this review we will summarize the current mechanistic insights as to how defects in cohesin and its regulators relate to pathology, with a particular focus on how altered chromatin architecture may participate in developmental disorders.
Cohesin and cohesion-related functions
Cohesin mediates sister chromatid cohesion from DNA replication in S-phase until chromosomes segregate during mitosis (reviewed in [3] )( Figure 3 ). In interphase SCC participates in maintaining genome stability by assisting recombinational repair of DNA double strand-breaks [2, 4] . In mitosis and meiosis cohesion ensures correct distribution of chromosomes and, therefore faithful transmission of genome from one generation of cells or individual to the next (reviewed in [5] ). The last twenty years of A c c e p t e d m a n u s c r i p t 5 research have uncovered numerous cohesin functional partners and regulators that act all along the cell cycle (Figures 1 and 3 ) and include cohesin modifying (Esco1 and Esco2, Aurora B and Plk1) and demodifying (PP2A, HDAC8) enzymes, chromatin loader (NIPBL-MAU2 complex) as well as cohesive and anti-cohesive factors (SA1 and 2, Sororin, Pds5A and B, Wapl, Sgo1L) that regulate and directly bind to cohesin complexes in a cell cycle regulated manner ( Figure 3 , for a detailed review on cohesin regulation see [6] ).
Beside roles related to its cohesive property, cohesin is also essential for proper functioning of the DNA damage checkpoint pathway [4] , a surveillance mechanism that halts cell cycle progression until all DNA damage has been repaired. More recently, cohesin and its regulators have been involved in centrosome biology. Recent findings suggested that cohesin hold mother and daughter centrioles and pericentriolar material through mechanisms and regulations that resemble that of chromatid cohesion [7, 8] although underlying molecular details are still elusive [9, 10] .
In addition to processes ensuring genome distribution and stability, cohesin also participates in other aspects of chromosome biology, which strikingly all impact on gene expression.
Cohesin's role for the regulation of gene expression
Along the vertebrate genome cohesin localizes in interphase to pericentric heterochromatin [11] and to discrete sites at chromosome arms [12] [13] [14] . The number of sites varies from about 10,000 to 60,000 depending on cell type, antibodies, technology platform and analysis pipeline [12, [15] [16] [17] . In all studies however, about 50 % of the cohesin sites localize in intergenic region, 37% in introns and exons and about 7% within 5kb upstream of promoters [12] . Notably, around 60 % to 80 % of the cohesin binding sites are co-occupied by the chromatin insulator CTCF [12] [13] [14] 16, 17] .
Cohesin sites without CTCF (cohesin/no CTCF) tend to be enriched at transcription start sites and are found to colocalize with cell-type specific transcription factors like estrogen receptor in MCF7 cells, or HNFA4 and CEBPA in HepG2 cells [16] . In mouse ES cells cohesin/no CTCF sites correlate with binding sites of the cohesin loader NIPBL and the mediator complex [17] . Also the transcription factor KIF4A was shown to be necessary to recruit cohesin to interacting regions [18] .
Cohesin/CTCF sites are involved in long-range interactions ( Figure 2 and 4) of the chromatin fibre, thereby mediating contacts between promoter and distal enhancers and gene activation at a number of developmentally important loci, for example the apolipoprotein gene cluster [19] , the imprinted gene cluster H19/IFG2 that controls embryonic growth [20] , the IFNG locus Studies using zebrafish and mouse as models revealed several pathways crucial for embryonic development, besides the aforementioned HOX genes, that might be affected by cohesin insufficiency.
In NIPBL heterozygous knockout mice the protocadherin genes (PCDH), clusters of genes that are expressed in an exclusive manner to provide neuronal identity, were found to be misregulated [54 •] .
Subsequent studies showed that cohesin-mediated DNA looping is involved in PCDH promoter choice [24, 55, 56] , indicating how cohesin insufficiencies might affect the developing brain.
Nipbl depletion in zebrafish produces a spectrum of specific heart and gut/visceral organ defects, reminiscent to the defects observed in CdLS. Analysis of gene expression changes revealed the misregulation of genes that are involved in gene regulatory networks controlling endodermal differentiation and left-right patterning [57 •] .
Altogether, these studies demonstrate that the effects of cohesin deficiencies in the developing embryo are highly complex. Multiple pathways are affected, either by a direct involvement of cohesin in the regulation of the gene or as downstream target.
Quite unexpectedly, and although all CdLS patient-derived cells reported so far display hypersensitivity to genotoxic stress, CdLS patients do not exhibit any cancer susceptibility caused by an altered response to DNA damage. This intriguing observation may be accounted for, at least partly, by a very protective patient environment, but has no satisfactory molecular explanation so far. Rare cases of cancer in CdLS A c c e p t e d m a n u s c r i p t 9 patients have been attributed to the consequences of malformations, like gastroesophageal reflux, but not to the genetic defect [60] .
An important issue concerns how mutations causative for tumorigenesis and for CdLS differ in their physiopathological outputs. Cohesin mutations found in either disease do not cluster in distinct, functionally relevant protein domains that would allow correlating particular mutations with given altered cohesin functions and thus with CdLS or tumorigenesis. This observation first suggests that cellular and developmental context, i.e. adult and terminally differentiated versus developing embryonic tissues, plays a key role in cellular consequences of given mutations. Second, it also indicates that acquisition of cohesin mutations might not initiate but contribute to tumorigenesis. Obviously much work will be required to decipher how individual cohesin mutations affect its many functions and how these alterations can account for human diseases.
Conclusion
Our concept of how cohesin regulates genes, in particular in context with disease, needs to evolve from single genes to gene regulatory networks and include the fact that cohesin insufficiency can affect individual genes via multiple mechanisms.
The challenge in the field will be to evaluate observations made under drastic knockdown conditions in the respective model systems for the relevance in the patient with a much milder depletion of the respective proteins. A c c e p t e d m a n u s c r i p t A c c e p t e d m a n u s c r i p t
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